Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Mechanistic study of the proangiogenic effect of osteoprotegerin.

Benslimane-Ahmim Z, Poirier F, Delomenie C, Lokajczyk A, Grelac F, Galy-Fauroux I, Mohamedi A, Fischer AM, Heymann D, Lutomski D, Boisson-Vidal C.

Angiogenesis. 2013 Jul;16(3):575-93. doi: 10.1007/s10456-013-9337-x. Epub 2013 Feb 6.

PMID:
23386104
2.

Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.

McGonigle JS, Giachelli CM, Scatena M.

Angiogenesis. 2009;12(1):35-46. doi: 10.1007/s10456-008-9127-z. Epub 2008 Dec 23.

PMID:
19105036
3.

Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells.

Kobayashi-Sakamoto M, Isogai E, Holen I.

Eur J Haematol. 2010 Jul;85(1):26-35. doi: 10.1111/j.1600-0609.2010.01446.x. Epub 2010 Mar 16.

PMID:
20331738
5.

Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation.

Kobayashi-Sakamoto M, Isogai E, Hirose K, Chiba I.

Microvasc Res. 2008 Nov;76(3):139-44. doi: 10.1016/j.mvr.2008.06.004. Epub 2008 Jul 4.

PMID:
18656492
6.

Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo.

Zauli G, Corallini F, Bossi F, Fischetti F, Durigutto P, Celeghini C, Tedesco F, Secchiero P.

Blood. 2007 Jul 15;110(2):536-43. Epub 2007 Mar 15.

7.

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.

Reid PE, Brown NJ, Holen I.

Mol Cancer. 2009 Jul 15;8:49. doi: 10.1186/1476-4598-8-49.

8.

Lipopolysaccharide impaired the functional activity of endothelial colony-forming cells.

Yu M, Zhang Q, Liu Q, Sun J, Yang G, Zeng G, Tan X.

Respiration. 2014;87(4):317-23. doi: 10.1159/000357438. Epub 2014 Jan 21.

9.

Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells.

Oh BJ, Kim DK, Kim BJ, Yoon KS, Park SG, Park KS, Lee MS, Kim KW, Kim JH.

Biochem Biophys Res Commun. 2010 Aug 6;398(4):627-33. doi: 10.1016/j.bbrc.2010.06.108. Epub 2010 Jul 1.

PMID:
20599766
10.

Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential.

Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, Laurendeau I, Galy-Fauroux I, Fischer AM, Boisson-Vidal C.

Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):644-50. doi: 10.1161/ATVBAHA.107.160044. Epub 2008 Jan 31.

11.

Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization.

Benslimane-Ahmim Z, Pereira J, Lokajczyk A, Dizier B, Galy-Fauroux I, Fischer AM, Heymann D, Boisson-Vidal C.

Cancer Lett. 2017 Jun 1;395:11-19. doi: 10.1016/j.canlet.2017.02.032. Epub 2017 Mar 3.

PMID:
28263839
12.

Role of full-length osteoprotegerin in tumor cell biology.

Zauli G, Melloni E, Capitani S, Secchiero P.

Cell Mol Life Sci. 2009 Mar;66(5):841-51. doi: 10.1007/s00018-008-8536-x. Review.

PMID:
19011755
13.

A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells.

Dias JV, Benslimane-Ahmim Z, Egot M, Lokajczyk A, Grelac F, Galy-Fauroux I, Juliano L, Le-Bonniec B, Takiya CM, Fischer AM, Blanc-Brude O, Morandi V, Boisson-Vidal C.

Biochem Pharmacol. 2012 Oct 15;84(8):1014-23. doi: 10.1016/j.bcp.2012.07.006. Epub 2012 Jul 14.

14.

Direct effects of osteoprotegerin on human bone cell metabolism.

Grundt A, Grafe IA, Liegibel U, Sommer U, Nawroth P, Kasperk C.

Biochem Biophys Res Commun. 2009 Nov 20;389(3):550-5. doi: 10.1016/j.bbrc.2009.09.026. Epub 2009 Sep 11.

PMID:
19748486
15.

alpha6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells.

Bouvard C, Gafsou B, Dizier B, Galy-Fauroux I, Lokajczyk A, Boisson-Vidal C, Fischer AM, Helley D.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1569-75. doi: 10.1161/ATVBAHA.110.209163. Epub 2010 May 27.

16.

Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N.

Mol Cancer Res. 2007 Jan;5(1):21-33.

17.

Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.

Nunes SS, Outeiro-Bernstein MA, Juliano L, Vardiero F, Nader HB, Woods A, Legrand C, Morandi V.

J Cell Physiol. 2008 Mar;214(3):828-37.

PMID:
17879962
18.

Agglucetin, a tetrameric C-type lectin-like venom protein, regulates endothelial cell survival and promotes angiogenesis by activating integrin alphavbeta3 signaling.

Wang WJ.

Biochem Biophys Res Commun. 2008 May 2;369(2):753-60. doi: 10.1016/j.bbrc.2008.02.091. Epub 2008 Feb 27.

PMID:
18312855
19.
20.

Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress.

Kim JY, Park YJ, Kim KJ, Choi JJ, Kim WU, Cho CS.

Arthritis Rheum. 2013 Aug;65(8):2172-82. doi: 10.1002/art.37997.

Supplemental Content

Support Center